Norbert von der Groeben
A substantial fraction of the estimated 15% of Americans carrying the high-risk gene variant of Alzheimer’s are protected to some degree from Alzheimer’s disease by a variant of the other gene. (A gene will often come in a variety of versions, or variants, that can produce different traits.)
The findings also may help drug developers better identify clinical trial participants and treatments for what, despite billions of dollars spent in pursuit of effective therapies, remains a disease without a cure.
About 5 million Americans – including roughly 1 in 10 people age 65 or older and one-third of those age 85 or older – have sy...
Read More
Recent Comments